BRIEF published on 04/22/2025 at 22:31, 1 year 4 months ago Allane SE Adjusts 2024 Earnings Forecast and Delays Reporting Dividend Suspension Allane SE 2024 Financial Forecast Earnings Deviation Financial Reporting Delay
BRIEF published on 04/22/2025 at 22:31, 1 year 4 months ago Allane SE ajuste ses prévisions de bénéfices pour 2024 et retarde la publication de ses résultats. Prévisions Financières 2024 Suspension Des Dividendes Allane SE Écart De Revenus Retard Dans Les Rapports Financiers
BRIEF published on 04/22/2025 at 22:10, 1 year 4 months ago Abivax : Modalités de l'Assemblée Générale Annuelle et perspectives 2025 Investissement Biotechnologie Abivax Essais Cliniques Assemblée Générale 2025
BRIEF published on 04/22/2025 at 22:10, 1 year 4 months ago Abivax: Terms of the Annual General Meeting and outlook for 2025 Biotechnology Abivax Clinical Trials Investment General Meeting 2025
BRIEF published on 04/22/2025 at 22:05, 1 year 4 months ago Abivax accueille le Dr Dominik Höchli au sein de son Conseil d’administration Abivax Conseil D'administration Phase 3 Immunologie Dominik Höchli
BRIEF published on 04/22/2025 at 22:05, 1 year 4 months ago Abivax welcomes Dr. Dominik Höchli to its Board of Directors Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
BRIEF published on 04/22/2025 at 21:56, 1 year 4 months ago PIERER Mobility AG Delays 2024 Financial Report Amid Restructuring Investor Negotiations PIERER Mobility 2024 Financial Report KTM Restructuring General Meeting Agenda
BRIEF published on 04/22/2025 at 21:56, 1 year 4 months ago PIERER Mobility AG retarde la publication de son rapport financier 2024 en raison d'une restructuration PIERER Mobilité Rapport Financier 2024 Négociations Avec Les Investisseurs Restructuration De KTM Ordre Du Jour De L'assemblée Générale
BRIEF published on 04/22/2025 at 20:00, 1 year 4 months ago Mangoceuticals Inc.: Transforming Men's Wellness Through Innovative Solutions Innovation Telemedicine Men's Health Erectile Dysfunction Mangoceuticals
BRIEF published on 04/22/2025 at 20:00, 1 year 4 months ago Mangoceuticals Inc. : Transformer le bien-être masculin grâce à des solutions innovantes Innovation Télémédecine Mangoceuticals Santé Des Hommes Dysfonction Érectile
Published on 09/11/2026 at 04:00, 3 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 9 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 16 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 07:30, 19 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 7 hours 44 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 49 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 9 hours 10 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 39 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 12 hours 20 minutes ago Availability of the 2026 Interim Financial Report
